Literature DB >> 8018534

Deletion analysis of chromosome 8p in sporadic colorectal adenomas.

C Cunningham1, M G Dunlop, C C Bird, A H Wyllie.   

Abstract

In order to assess the stage of colorectal tumorigenesis at which chromosome 8p loss of heterozygosity (LOH) occurs, 56 sporadic adenomas were examined for LOH at four polymorphic loci which show frequent LOH in carcinomas. LOH was found in only 5 out of 51 (9.8%) informative adenomas, whereas studies with the same markers in 85 informative carcinomas showed a LOH of 45%. The adenomas showing LOH were all in the 'high-risk' clinicopathological category, being 10 mm or more in diameter and showing tubulovillous architecture. It is concluded that the chromosome 8p locus is involved preferentially in the development of carcinomas rather than adenomas.

Entities:  

Mesh:

Year:  1994        PMID: 8018534      PMCID: PMC2033333          DOI: 10.1038/bjc.1994.243

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma.

Authors:  M Emi; Y Fujiwara; H Ohata; H Tsuda; S Hirohashi; M Koike; M Miyaki; M Monden; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

2.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

3.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

4.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Authors:  M Emi; Y Fujiwara; T Nakajima; E Tsuchiya; H Tsuda; S Hirohashi; Y Maeda; K Tsuruta; M Miyaki; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

Authors:  M A Knowles; M E Shaw; A J Proctor
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

7.  Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.

Authors:  Y Fujiwara; M Emi; H Ohata; Y Kato; T Nakajima; T Mori; Y Nakamura
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

8.  Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3.

Authors:  C Cunningham; M G Dunlop; A H Wyllie; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

9.  Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

Authors:  P Carder; A H Wyllie; C A Purdie; R G Morris; S White; J Piris; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

View more
  2 in total

1.  Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum.

Authors:  J D Mueller; N Haegle; G Keller; E Mueller; G Saretzky; B Bethke; M Stolte; H Höfler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

2.  Allelic imbalance of 8p indicates poor survival in gastric cancer.

Authors:  Amy J French; Gina Petroni; Stephen N Thibideau; Mark Smolkin; Eric Bissonette; Franco Roviello; Jeffrey C Harper; Benjamin R Koch; Sarah A Anderson; Scott J Hebbring; Steven M Powell
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.